[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100547923":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":10,"locations":23,"responsibleParty":44,"collaborators":46,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":10,"eligibilityCriteria":56,"healthyVolunteers":52,"sex":57,"minAge":58,"maxAge":10,"enrollmentInfo":59,"targetDuration":10,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":10,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Masonic Cancer Center, University of Minnesota","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational",null,"Patients complete SALSA assessment and ICE assessments on study. Patients also have their medical records reviewed on study.",[13],"Other: Non-Interventional Study",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Non-Interventional Study","Non-interventional study",[9],[20],{"name":21,"affiliation":5,"role":22},"Veronika Bachanova","PRINCIPAL_INVESTIGATOR",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"University of Minnesota\u002FMasonic Cancer Center","RECRUITING","Minneapolis","Minnesota","55455","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-93.26384,44.97997,{"lat":36,"lon":35},[39,43],{"name":21,"role":40,"phone":41,"phoneExt":10,"email":42},"CONTACT","612-625-5469","bach0173@umn.edu",{"name":21,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":45,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[47],{"name":48,"class":49},"National Cancer Institute (NCI)","NIH","100547923","evaluation-of-early-identification-of-cognitive-side-effects-of-immunotherapy-100547923",false,"NCT06414278","Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy","Early Identification of Cognitive Side-Effects of Immunotherapy","Inclusion Criteria:\n\n* \\* ≥ 18 years of age at initiation of therapy\n\n  * Planning to undergo inpatient CAR-T therapy for primary malignancy\n  * Fluent in English (written or spoken)\n\nExclusion Criteria:\n\n* \\* Subjects with speech or hearing impediment that would make them unable to be assessed with SALSA\n\n  * Subjects with diagnosed cognitive impairment prior to CAR-T therapy\n  * Unwilling or unable to sign voluntary written consent","ALL","18 Years",{"count":60,"type":61},38,"ESTIMATED","OBSERVATIONAL","This clinical trial evaluates the use of a tool kit, Stress, Affect, Language and Speech Analysis (SALSA), for early identification of cognitive side effects of immunotherapy compared to the standard of care assessment.",[65,66],"Hematopoietic and Lymphatic System Neoplasm","Malignant Solid Neoplasm","2026-01-12",{"date":69,"type":70},"2026-01-13","ACTUAL",{"date":72,"type":70},"2024-02-08",{"date":74,"type":61},"2028-02-21",{"name":5,"class":6},1]